Lupin intros Tydemi, its Safyral generic

Lupin has launched its contraceptive Tydemy, which was approved by the Food and Drug Administration in December as a generic of Bayer’s Safyral. Tydemy, (drospirenone, ethinyl estradiol, and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets, 0.451 mg) are indicated to preven pregnancy and raise folate levels in women who prefer an oral contraceptive.

The drug had U.S. sales of roughly $22 million for the 12 months ended January 2018.